The News Review:

- 43 CE of Institute of Clinical Research (India)
- Neurorealism – New York Times
- A dose of reality
- NWAnews.com :: Northwest Arkansas’ News Source
- £5m centre to lead cancer battle
- Netherlands Corporate News – Medidata Solutions realiseert 26ste…

43 CE of Institute of Clinical Research (India)
Expressindia.com – Dec 9, 2007
An Indian product or service you can’t do without?An Indian massage. I feel relaxed whenever I having one. Any fashion tips?Guys should tone down the colour of their shirts. Girls should retain the sense of India in their attire even if they are wearing a sari or a kurta. Dared to try street food?I had pav bhaji at Juhu beach. It was wonderful and having it on the beach made it more delicious. A phrase you’re bound to hear?”Theek hai.

Neurorealism – New York Times
New York Times – Dec 9, 2007
A paper published online in September by the journal Cognition shows that assertions about psychology even implausible ones like “watching television improved math skills” seem much more believable to laypeople when accompanied by images from brain scans. And a paper accepted for publication by The Journal of Cognitive Neuroscience demonstrates that adding even an extraneous reference to the brain to a bad explanation of human behavior makes the explanation seem much more satisfying to nonexperts. Eric Racine a bioethicist at the Montreal Clinical Research Institute coined the word neurorealism to describe this form of credulousness. In an article called “fMRI in the Public Eye” he and two colleagues cited a Boston Globe article about how high-fat foods activate reward centers in the brain. The Globe headline: “Fat Really Does Bring Pleasure. ” Couldn’t we have proved that with a slice of pie and a piece of paper with a check box on it?The way conclusions from cognitive neuroscience studies are reported in the popular press “they don’t necessarily tell us anything we couldn’t have found out without using a brain scanner” says Deena Weisberg an author of the Journal of Cognitive Neuroscience paper. “It just looks more believable now that we have the pretty pictures.

A dose of reality
Times of India – Dec 9, 2007
How far is it in application today? Avery limited extent. It’s a little too early to promise patients?custom-built medication? except in select situations” cautions DrKalpana Swaminathan a Mumbai-based pediatricsurgeon. “With the advent ofantibiotics and good clinical research the fields of gastroenterology andmedicine have grown a manifold. Diseases which were thought not to be curableare now in the grasp of doctors. Drugs have progressed a lot. The ongoingeradication of H. Pylori has been achieved because of antibiotics” says DrPrasanna Shah consultant gastroenterologist Jaslok Hospital Mumbai.

NWAnews.com :: Northwest Arkansas’ News Source
nwanews.com – Dec 9, 2007
Lilly however says it is “very pleased with the trial’s outcome. ” The other study was a postmortem on Pfizer’s torcetrapib already known as one of the industry’s most costly failures with $ 800 million in budgeted research costs. “There haven’t been any new therapies that are proven to reduce death and disability for atherosclerosis since the introduction of the [cholesterollowering ] statins” in the late 1980 s said Richard C. Pasternak vice president of Cardiovascular Clinical Research at Merck. Atherosclerosis a buildup of arterial plaque is a major cause of heart disease. CMPANIES RERGANIZING As patent expirations loom pharmaceutical companies are reorganizing. In five years many may look very different.

£5m centre to lead cancer battle
Manchester nline – Manchester nline – Dec 9, 2007
The centre will be based in newly-refurbished laboratories at the Patterson Institute of Cancer Research next to The Christie Manchester’s specialist cancer hospital. It will have close links with the newly-opened Nightingale Centre and Genesis Prev- ention Centre at Wythenshawe. Anthony Howell professor of medical oncology at Manchester University who will be the director of the new unit said: “It will draw on the enormous strengths in basic and clinical research which exist here and our work will focus on ways to diagnose breast cancer earlier and prevent the disease from occurring. “Along with our existing research interests in this field this centre has the potential to make Manchester one of the top breast cancer research clusters in Europe if not worldwide. “The aim of our work will be to create new more sophisticated treatments and more accurately predict which therapies are most likely to succeed for any individual. Charles Streuli professor of cell biology at Manchester University and Nigel Bundred professor in surgical oncology at the University Hospital of South Manchester and Christie hospitals will also be directors of the new unit. Breast cancer is the most common cancer in Britain yet survival rates are among the lowest in Europe.

Netherlands Corporate News – Medidata Solutions realiseert 26ste…
Netherlands Corporate News – Netherlands Corporate News (persbericht) – Dec 9, 2007
“We’re pleased to attribute our continued growth this quarter to asignificant number of follow-on contracts with existing customers newsponsor commitments to Medidata Rave and additional clients broughton as a result of our partnerships with the industry’s leading CRs”said Tarek Sherif CE of Medidata Solutions. “Through our strategicaddition of key global customers partners and Medidata staff we’vegreatly increased our market presence this quarter and look forward tofurther success through the second half of the year. About Medidata Solutions Worldwide Medidata Solutions helps the world’s leading pharmaceuticalbiotechnology medical device and research organizations maximize thevalue of their clinical research investments. Innovative processdesign technology and services streamline clinical trials byproviding early visibility to reliable clinical data – the lifebloodof every research organization. Working with companies andinstitutions both large and small Medidata Solutions helps clinicalresearchers safely accelerate the process of bringing life-enhancingtreatments to market – on six continents and in more than 80countries. Medidata Solutions brings significant value to its broadclient base with deep clinical experience and expertise in more than20 therapeutic areas projects in Phase I II III IV registries andsurveillance and studies with thousands of investigators andtens-of-thousands of subjects. For more information please visitwww.